These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38942808)

  • 1. SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19.
    Kim DM; Lawrence Panchali MJ; Kim CM; Lee DY; Seo JW; Kim DY; Yun NR
    Sci Rep; 2024 Jun; 14(1):14926. PubMed ID: 38942808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.
    Olea B; Albert E; Torres I; Gozalbo-Rovira R; Carbonell N; Ferreres J; Poujois S; Costa R; Colomina J; Rodríguez-Díaz J; Blasco ML; Navarro D
    J Med Virol; 2022 Jan; 94(1):222-228. PubMed ID: 34449894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.
    Lawrence Panchali MJ; Kim CM; Seo JW; Kim DY; Yun NR; Kim DM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients.
    Costa R; Alberola J; Olea B; Gozalbo-Rovira R; Giménez E; Cuevas-Ferrando E; Torres I; Albert E; Carbonell N; Ferreres J; Sánchez G; Rodríguez-Díaz J; Blasco ML; Navarro D
    Sci Rep; 2022 May; 12(1):8273. PubMed ID: 35585163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
    Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N
    J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
    Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
    Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
    Miki S; Sasaki H; Horiuchi H; Miyata N; Yoshimura Y; Miyazaki K; Matsumura T; Takahashi Y; Suzuki T; Matano T; Kawana-Tachikawa A; Tachikawa N
    PLoS One; 2021; 16(7):e0254640. PubMed ID: 34255796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19.
    Wang H; Hogan CA; Verghese M; Solis D; Sibai M; Huang C; Röltgen K; Stevens BA; Yamamoto F; Sahoo MK; Zehnder J; Boyd SD; Pinsky BA
    Clin Chem; 2021 Dec; 68(1):204-213. PubMed ID: 34605900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.
    Camou F; Tinevez C; Beguet-Yachine M; Bellecave P; Ratiarison D; Tumiotto C; Lafarge X; Guisset O; Mourissoux G; Lafon ME; Bonnet F; Issa N
    J Med Virol; 2021 Sep; 93(9):5594-5598. PubMed ID: 33942327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.
    van Riel D; Embregts CWE; Sips GJ; van den Akker JPC; Endeman H; van Nood E; Raadsen M; Bauer L; van Kampen J; Molenkamp R; Koopmans M; van de Vijver D; GeurtsvanKessel CH
    mSphere; 2021 Jun; 6(3):e0031121. PubMed ID: 34047654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study.
    Xu D; Zhou F; Sun W; Chen L; Lan L; Li H; Xiao F; Li Y; Kolachalama VB; Li Y; Wang X; Xu H
    Clin Infect Dis; 2021 Jul; 73(1):68-75. PubMed ID: 32720678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.
    Gutmann C; Takov K; Burnap SA; Singh B; Ali H; Theofilatos K; Reed E; Hasman M; Nabeebaccus A; Fish M; McPhail MJ; O'Gallagher K; Schmidt LE; Cassel C; Rienks M; Yin X; Auzinger G; Napoli S; Mujib SF; Trovato F; Sanderson B; Merrick B; Niazi U; Saqi M; Dimitrakopoulou K; Fernández-Leiro R; Braun S; Kronstein-Wiedemann R; Doores KJ; Edgeworth JD; Shah AM; Bornstein SR; Tonn T; Hayday AC; Giacca M; Shankar-Hari M; Mayr M
    Nat Commun; 2021 Jun; 12(1):3406. PubMed ID: 34099652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
    Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
    J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.